TARGET RWE
LIVE

Serial Number

88907357

Owner

Target PharmaSolutions, Inc.

Attorney

Shaun J. Bockert

First Use Date

Aug 9, 2020

Filing Date

May 8, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TARGET RWE Trademark

Serial Number: 88907357 • Registration: 6330371

TARGET RWE is a trademark filed by Target PharmaSolutions, Inc. on May 8, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Target PharmaSolutions, Inc. (4 trademarks)

6409 Fayetteville Rd, Suite 120 #377
Durham, NC 27713

Entity Type: 03

Trademark Details

Filing Date

May 8, 2020

Registration Date

April 20, 2021

First Use Anywhere

August 9, 2020

First Use in Commerce

August 9, 2020

Published for Opposition

November 24, 2020

Goods & Services

Marketing consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillance; Business services provided to the life sciences industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Data processing services in the field of post-marketing drug safety and surveillance

Regulatory compliance consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillance

Scientific research consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillance; Providing medical and scientific research information in the field of pharmaceuticals; Clinical research and testing services in the fields of pharmaceuticals; Product development consultation in the fields of pharmaceuticals; Consulting services in the field of pharmaceutical research; Medical and scientific research in the field of post-marketing drug safety and surveillance; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research in the field of pharmaceuticals

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 20, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 20, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 16, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 15, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 20, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 17, 2021 AITU
USE AMENDMENT FILED
Jan 26, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 26, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 19, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 24, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 24, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 4, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 2, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 28, 2020 GNFN
FINAL REFUSAL E-MAILED
Sep 28, 2020 GNFR
FINAL REFUSAL WRITTEN
Sep 28, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 1, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 6, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 6, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2020 NWOS
NEW APPLICATION ENTERED
May 12, 2020 NWAP